L&C Bio Co., Ltd
KOE: 290650.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Chul Lee Whan
- Employees
- 128
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2018
- Market cap
- ₩1.5T
- Website
- http://www.lncbio.co.kr
Loading 290650…
Loading profile data…Frequently asked questions about 290650
What does L&C Bio Co., Ltd (290650.KQ) do?
L&C BIO Co., Ltd. operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam, South Korea.
Where does 290650.KQ trade?
L&C Bio Co., Ltd (290650.KQ) trades on the KOSDAQ.
What sector is 290650.KQ in?
L&C Bio Co., Ltd (290650.KQ) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of L&C Bio Co., Ltd?
Chul Lee Whan is the chief executive officer of L&C Bio Co., Ltd (290650.KQ).
Where is L&C Bio Co., Ltd headquartered?
L&C Bio Co., Ltd is headquartered in South Korea.
Does 290650.KQ pay a dividend?
Yes — L&C Bio Co., Ltd (290650.KQ) paid a trailing twelve-month dividend of KRW 50.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 290650.KQ go public?
L&C Bio Co., Ltd (290650.KQ) completed its initial public offering in 2018.